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Endovascular stent-graft repair for penetrating
atherosclerotic ulcer in the infrarenal abdominal
aorta
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Purpose: Penetrating atherosclerotic ulcer (PAU) is an ulceration of an atherosclerotic plaque penetrating through the
intima, which may lead to intramural hematoma, aneurysm formation, or rupture. This disease is predominantly found
in the thoracic aorta and is uncommon in the infrarenal aorta. The effectiveness of endovascular repair of PAU in the
infrarenal aorta was retrospectively investigated.
Methods: From 1999 to 2002, PAU was diagnosed with computed tomography and magnetic resonance imaging in the
abdominal aorta in four patients. All patients were men; their average age was 78 years. All four patients had
hypertension, and two patients had concomitant coronary artery disease. Three patients had abdominal pain or lumbago.
Results: All patients underwent endovascular grafting with a Gianturco Z-stent covered with thin-wall woven Dacron
graft. Indications for endovascular intervention were aneurysm formation with or without intramural hematoma in two
patients and contained rupture with extraaortic hematoma in two patients. The postoperative course was uneventful in
all cases, and no endoleak or aneurysm expansion was recognized during follow-up (4-32 months; average, 14 months).
Conclusions: Infrarenal aortic lesions caused by PAU were generally localized, and endovascular grafting appears to be a
feasible alternative to surgical repair. (J Vasc Surg 2003;38:383-8.)
Penetrating atherosclerotic ulcer (PAU) of the aorta is
ulceration of an atherosclerotic plaque penetrating through
the intima, and it may be complicated by aortic intramural
hematoma, adventitial pseudoaneurysm formation, or aor-
tic rupture1,2 (Fig 1). PAU occurs predominantly in the
descending thoracic aorta, and it is uncommon in the
infrarenal aorta.3,4 We reviewed clinical features of PAU in
the infrarenal aorta and investigated the usefulness of en-
dovascular repair for this rare lesion.
METHODS
Patient characteristics. Between 1999 and 2002,
PAU of the abdominal aorta was diagnosed in four patients
(Table). All patients were men, and their ages ranged from
66 to 89 years (average age, 78 years). Three patients
previously had abdominal pain or lumbago. Hypertension
was preoperatively detected in all four patients, and coro-
nary artery disease was detected in two patients.
PAU was diagnosed at computed tomography (CT)
and magnetic resonance imaging (MRI). Intramural hema-
toma with aortic expansion (case 1; Fig 2A,), adventitial
pseudoaneurysm formation without intramural hematoma
(case 2; Fig 3A,), and contained ruptures with extra-aortic
hematoma (cases 3 and 4; Fig 4A,) were recognized. Aor-
tography was performed to assess the femoral access route,
anatomy of the abdominal aorta (Fig 4B), and location of
PAU (Fig 2, B; Fig 4, B).
Endovascular procedure. The stent graft was con-
structed of a self-expanding Gianturco Z-stent (GZV;
Cook Inc, Bjaeverskov, Denmark) covered with thin-wall
Dacron graft (UBE woven graft, porosity 150 mL/min/
cm2; Ube Inc, Yamaguchi, Japan).
After systemic heparinization and preoperative aortog-
raphy, an 18F delivery sheath catheter (catheter introducer
kit; Medikit Co, Tokyo, Japan) with the stent graft loaded
inside was introduced into the femoral artery over the guide
wire. The stent graft was deployed over the lesion under
fluoroscopic guidance and tug-of-wire maneuvering. Bal-
loon dilation was usually used also. Finally, completion
aortography was performed to confirm successful deploy-
ment of the stent graft.
In three cases endovascular stent grafting was per-
formed with the patient under local anesthesia in an an-
giography suite. One patient who had adventitial pseudo-
aneurysm after PAU and acute cholecystitis underwent
simultaneous repair of both complications in the operating
theater. With the patient under general anesthesia, endo-
vascular stent grafting was performed first, from the femo-
ral approach, followed by cholecystectomy through a right
subcostal incision.
To evaluate endoleak, stent-graft migration, and aneu-
rysm diameter, follow-up contrast material–enhanced CT
was performed before hospital discharge and every 3 to 6
months thereafter.
RESULTS
Deployment of the stent graft was technically successful
in all patients. Aortograms obtained after the procedure
demonstrated no endoleak and complete exclusion of
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PAU or pseudoaneurysm (Fig 2C). Mean operative time
was 115.5 minutes (range, 90-165 minutes). Mean blood
loss was less than 100 g, and no blood transfusion was
needed.
Postoperative course in all patients was uneventful.
Contrast-enhanced CT scans obtained before hospital dis-
charge demonstrated that all stent grafts were in the correct
position, and all types of endoleak were absent (Fig 3B).
Mean hospital stay after the operation was 13.8 days (range,
8-26 days).
During follow-up of 4 to 32 months (average, 14
months) no endoleak or aneurysm expansion was recog-
nized in any patient. Average aneurysm shrinkage ratio
(postoperative/preoperative aneurysm diameter) was 0.9
(range, 0.8-1.0) at 6-month follow-up and 0.87 (range,
0.73-1.0) at 12 months. One 89-year-old man died of
nonrelated disease 7 months after the operation. The re-
maining three patients are alive without recurrence of dis-
ease.
DISCUSSION
PAU of the aorta was first described as a distinct clinical
and pathologic entity by Stanson et al1 in 1986. The
condition is characterized by ulceration of an atheroscle-
Fig 1. Schema of clinical course of penetrating atherosclerotic ulcer of the aorta. This lesion may lead to aortic
intramural hematoma, adventitial pseudoaneurysm, and rupture with extra-aortic hematoma. Calcified plaques
detected on plain CT scans are useful markers for differential diagnosis of intramural hematoma and intraluminal
thrombus, and true aneurysm and adventitial pseudoaneurysm.
Table 1. Clinical characteristics of patients with PAU in infrarenal abdominal aorta
Patient
Age
(y) Gender Onset Symptoms HT CAD
Radiologic findings
Prognosis (mo)
Shaggy
aorta
Calicifi-
cation Associated condition
1 72 M Chronic None     Intramural hematoma Alive (32)
2 89 M Acute Abdominal pain  NA   Adventitial pseudoaneurysm Death (7)
3 85 M Chronic Abdominal pain     Contained rupture with
hematoma
Alive (11)
4 66 M Chronic Lumbago     Contained rupture with
hematoma
Alive (4)
CAD, Coronary artery disease; HT, hypertension; NA, not assessed; PAU, penetrating atherosclerotic ulceration.
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Fig 2. Patient 1. Penetrating atherosclerotic ulcer in the abdominal aorta, with intramural hematoma.A, Preoperative
contrast-enhanced CT scan. B, Preoperative aortogram shows localized contrast-filled outpouching in the infrarenal
aorta. C, Aortogram after deployment of the stent graft demonstrates that the lesion has been completely sealed.
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Fig. 3. Patient 2. Penetrating atherosclerotic ulceration in the abdominal aorta with pseudoaneurysm.A, Preoperative
contrast-enhanced CT scan. B, Contrast-enhanced CT scan obtained 8 days after endovascular stent grafting
demonstrates complete exclusion of the lesion and the adventitial pseudoaneurysm.
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rotic plaque that penetrates through the elastic lamina and
into the media. Subsequently, hematoma formation may
extend along the media, and in some cases hematoma
extension causes stretching of the weakened aortic adven-
titia, forming a saccular pseudoaneurysm. Intramural he-
matoma and pseudoaneurysm associated with PAU may
eventually rupture, and it may be speculated that some
spontaneous aortic ruptures in elderly patients may be due
to perforation of PAU. PAU should be distinguished from
true aneurysm and classic aortic dissection; however, differ-
entiation of these disease entities is sometimes difficult, and
there seems to be confusion regarding the concept of
PAU.5
PAU generally affects elderly patients with advanced
athrosclerosis. As a result, PAU is associated with a high
incidence of morbidity, eg, hypertension, coronary artery
disease, and carotid artery occlusive disease. All four pa-
tients in this series have received antihypertensive drugs,
and two patients had coronary artery disease.
PAU may be diagnosed at CT, MRI, and conventional
aortography; however, a high degree of clinical suspicion is
necessary for diagnosis of PAU. Extensive aortic calcifica-
tion is often detected on plain CT scans, and development
of intramural hematoma after PAU versus intraluminal
thrombus can be differentiated by the location of calcified
plaques in relation to the thrombus on plain CT scans. On
contrast-enhanced CT scans, PAU is recognized as a con-
trast-filled, pouchlike aortic protrusion without a dissection
flap or false lumen. The intramural hematoma, advential
pseudoaneurysm, and rupture with extra-aortic hematoma
may also be seen. However, it is sometimes difficult to
differentiate extra-aortic hematoma after rupture of PAU
and periaortic tumors invading the aortic wall.6 MRI is
useful in differential diagnosis in such cases, and MRI has
the additional advantage of allowing multiplane imaging
without use of contrast medium. 7,8
Some authors believe immediate surgical treatment is
not always required, because most PAU have a benign
clinical course.3,4 However, early intervention is recom-
mended when PAU is complicated with aneurysm expan-
sion, rupture, embolic symptoms, or uncontrolled pain.
Open surgical repair with graft interposition has been used
for such symptomatic PAU, but patients with PAU are
generally not ideal candidates for open repair because of
advanced age and poor general status. High operative
morbidity and mortality associated with open repair have
been reported.1,9
As a less invasive treatment for this disease, endovascu-
lar stent grafting was first used by the Stanford group.10,11
Subsequently, several reports of successful endovascular
treatment of PAU have been published.4,6,12-16 Review of
the 32 cases reported to date, including our own, reveals
that deployment of the stent graft was successful in all.
Early complications have included transient or permanent
paraplegia in three patients, and primary endoleak, which
spontaneously regressed, in four patients. During follow-
up, aneurysm recurrence was reported as a treatment-re-
lated complication in two patients, and was suspected to be
Fig. 4. Patient 4. Penetrating atherosclerotic ulceration in the
abdominal aorta with extra-aortic hematoma. A, Preoperative
contrast-enhanced CT scan. B, Preoperative aortogram shows
contrast-filled protrusion in the infrarenal shaggy aorta.
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caused by persistent endoleak and iatrogenic intimal injury
during deployment of the stent graft. As most patients who
received the stent grafts to repair PAU were in a high-risk
cohort, the advantages of stent grafting are changing the
strategy for treatment of symptomatic PAU. The lower
morbidity and mortality after stent-graft repair also sup-
ports a more aggressive approach to this lesion, even in
patients with symptoms.
PAU typically involves the descending thoracic aorta,
and it is comparatively rare that PAU develops in the
infrarenal abdominal aorta. To our knowledge, 18 patients
with PAU in the infrarenal abdominal aorta have been
reported. Fourteen were followed up medically, and 4
underwent open surgical repair.2-4,17,18 We have found no
report dealing with endovascular stent grafting for treat-
ment of PAU in the infrarenal abdominal aorta.
In conclusion, infrarenal aortic lesions caused by PAU
are generally localized, and endovascular stent grafting for
repair of this disease appears to be a feasible alternative to
surgical repair. Initial results of endovascular treatment of
PAU are satisfactory; however, further investigations of the
long-term results of this procedure are necessary.
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